BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 8621793)

  • 21. In vivo regulation of adrenocorticotrophin secretion in the immature ovine fetus. Modulation by ovine corticotrophin releasing hormone and arginine vasopressin.
    MacIsaac RJ; Congiu M; Levidiotis M; McDougall JG; Wintour EM
    J Dev Physiol; 1989 Jul; 12(1):41-7. PubMed ID: 2559117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
    Bugajski J; Borycz J; Gadek-Michalska A; Głód R
    J Physiol Pharmacol; 1998 Dec; 49(4):607-16. PubMed ID: 10069701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of bilateral inferior petrosal sinus sampling (BIPSS) in the diagnosis of Cushing's disease.
    Lin LY; Teng MM; Huang CI; Ma WY; Lin LY; Teng MM; Huang CI; Ma WY; Wang KL; Lin HD; Won JG
    J Chin Med Assoc; 2007 Jan; 70(1):4-10. PubMed ID: 17276926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term secretion patterns of corticotropin-releasing hormone, arginine vasopressin and ACTH as shown by intensive sampling of pituitary venous blood from horses.
    Alexander SL; Irvine CH; Donald RA
    Neuroendocrinology; 1994 Sep; 60(3):225-36. PubMed ID: 7969780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrin-releasing peptide stimulation of corticotropin secretion in male rats.
    Olsen L; Knigge U; Warberg J
    Endocrinology; 1992 May; 130(5):2710-6. PubMed ID: 1315254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats.
    Katoh K; Yoshida M; Kobayashi Y; Onodera M; Kogusa K; Obara Y
    J Endocrinol; 2005 Nov; 187(2):249-56. PubMed ID: 16293772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of vasopressin and elimination of corticotropin-releasing hormone-target cells on pro-opiomelanocortin mRNA levels and adrenocorticotropin secretion in ovine anterior pituitary cells.
    van de Pavert SA; Clarke IJ; Rao A; Vrana KE; Schwartz J
    J Endocrinol; 1997 Jul; 154(1):139-47. PubMed ID: 9246948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurohypophysial peptides. Histaminergic regulation and function in adenohypophysial secretion.
    Kjaer A
    Dan Med Bull; 1996 Dec; 43(5):391-406. PubMed ID: 8960813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked changes of arginine vasopressin, oxytocin, and corticotropin-releasing hormone in hypophysial portal plasma after pituitary stalk damage in the rat.
    Makara GB; Sutton S; Otto S; Plotsky PM
    Endocrinology; 1995 May; 136(5):1864-8. PubMed ID: 7720631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Simultaneous and bilateral catheterization of inferior petrosal sinuses in the diagnosis of Cushing's syndrome: basal multiple sampling and after ACTH-releasing hormone test].
    Zarrilli S; Filippella M; Lucci R; Esposito P; Paesano L; De Rosa M; Colao A
    Chir Ital; 1998; 50(2-4):9-15. PubMed ID: 11762085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studies.
    Merola B; Longobardi S; Colao A; Di Somma C; Ferone D; Di Rella F; Pivonello R; Covelli V; Annunziato L; Lombardi G
    Neuroendocrinology; 1996 Nov; 64(5):393-7. PubMed ID: 8930939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histamine- and stress-induced secretion of ACTH and beta-endorphin: involvement of corticotropin-releasing hormone and vasopressin.
    Kjaer A; Knigge U; Bach FW; Warberg J
    Neuroendocrinology; 1992 Sep; 56(3):419-28. PubMed ID: 1331840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxytocin at physiological concentrations evokes adrenocorticotropin (ACTH) release from corticotrophs by increasing intracellular free calcium mobilized mainly from intracellular stores. Oxytocin displays synergistic or additive effects on ACTH-releasing factor or arginine vasopressin-induced ACTH secretion, respectively.
    Link H; Dayanithi G; Föhr KJ; Gratzl M
    Endocrinology; 1992 Apr; 130(4):2183-91. PubMed ID: 1312449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticotrophin-releasing factors in the hypothalamus of the developing fetal sheep.
    Currie IS; Brooks AN
    J Dev Physiol; 1992 May; 17(5):241-6. PubMed ID: 1281183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.